Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Paul Ausick | May 24, 2019 at 4:33 PM EDT

Bad Diet Could Be to Blame for a Surprisingly High Share of Cancer Cases

New research discusses links between diet and cancer risk for Americans.

Jon C. Ogg | May 23, 2019 at 11:40 AM EDT

Citigroup Sees Big Upside for 2 of the Largest Biotechs

Despite the wearing down of hepatitis C drugs and the political climate targeting drug prices, this analyst sees stabilization and…

Chris Lange | May 23, 2019 at 10:35 AM EDT

How Tonix Pharma Is Kicking Cocaine

Tonix Pharmaceuticals shares jumped on Thursday after the firm announced that it has in-licensed a Phase 2 asset, TNX-1300 for…

Chris Lange | May 22, 2019 at 11:40 AM EDT

How Eli Lilly Is Making Insulin More Affordable

Eli Lilly has announced that its Insulin Lispro Injection is now available for order in pharmacies for people who use…

Chris Lange | May 21, 2019 at 1:40 PM EDT

Why Ocular Therapeutix Fell Short in Its Glaucoma Study

Ocular Therapeutix shares took a beating on Tuesday after the firm announced late-stage results for patients with primary open-angle glaucoma…

Chris Lange | May 21, 2019 at 10:10 AM EDT

Why BioCryst’s HAE Treatment Failed to Impress

BioCryst Pharmaceuticals shares were absolutely crushed in Tuesday’s session after the company announced late-stage results for its study in hereditary…

Paul Ausick | May 20, 2019 at 11:13 AM EDT

We May Have Been Wrong About the Connection Between Coffee and Poop for Years

New research indicates that caffeine may not be the reason that some coffee drinkers feel a need for a bowel…

Chris Lange | May 16, 2019 at 4:03 PM EDT

Thursday’s Top 4 ASCO Movers

This is known as the world’s largest clinical cancer conference, and it always delivers new results on clinical trials and…

Jon C. Ogg | May 16, 2019 at 2:10 PM EDT

Can Danaher Walk Away From the Buyout of GE’s Biopharma Unit?

If there is one former Dow Jones industrial average leader that is in need of serious help, look no further…

Chris Lange | May 16, 2019 at 11:35 AM EDT

Solid Breast Cancer Results From MacroGenics Ahead of ASCO

MacroGenics announced additional details of the results from the Phase 3 Sophia study of margetuximab in patients with HER2-positive metastatic…

Hristina Byrnes | May 16, 2019 at 11:29 AM EDT

These Are the Most Used Drugs in the World — And Opioids Aren’t Even in the Top 5

About 53 million people worldwide use opioids or their natural counterparts and nearly half of them develop substance-abuse disorders leading…

Chris Lange | May 16, 2019 at 9:55 AM EDT

Iovance Bio’s Big Break in Cervical Cancer Ahead of ASCO

Iovance Biotherapeutics is one of the early big winners from ASCO. The firm announced updates from ongoing clinical trials including…

Paul Ausick | May 15, 2019 at 12:30 PM EDT

Why Agilent Stock Plunged 12% After Earnings

Health care instrument maker Agilent is getting hammered Wednesday following a worse-than-expected earnings report for the company's second fiscal quarter.…

Chris Lange | May 14, 2019 at 1:25 PM EDT

Why There May Be a Big Issue With This Duchenne Muscular Dystrophy Study

Solid Biosciences shares were crumbling on Tuesday after the firm announced its first-quarter results and an update to its midstage…

Chris Lange | May 14, 2019 at 9:38 AM EDT

The Best Biotech ETFs to Buy Ahead of ASCO

The 55th annual meeting of the American Society of Clinical Oncology (ASCO) is just around the corner. Biotech and pharmaceutical…

1 … 98 99 100 101 102 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Bad Diet Could Be to Blame for a Surprisingly High Share of Cancer Cases

Citigroup Sees Big Upside for 2 of the Largest Biotechs

How Tonix Pharma Is Kicking Cocaine

How Eli Lilly Is Making Insulin More Affordable

Why Ocular Therapeutix Fell Short in Its Glaucoma Study

Why BioCryst’s HAE Treatment Failed to Impress

We May Have Been Wrong About the Connection Between Coffee and Poop for Years

Thursday’s Top 4 ASCO Movers

Can Danaher Walk Away From the Buyout of GE’s Biopharma Unit?

Solid Breast Cancer Results From MacroGenics Ahead of ASCO

These Are the Most Used Drugs in the World — And Opioids Aren’t Even in the Top 5

Iovance Bio’s Big Break in Cervical Cancer Ahead of ASCO

Why Agilent Stock Plunged 12% After Earnings

Why There May Be a Big Issue With This Duchenne Muscular Dystrophy Study

The Best Biotech ETFs to Buy Ahead of ASCO

Is Jeff Bezos’ New Startup An Even Bigger Idea than Amazon? He Tells CNBC it Will Drive ‘Civilizational Wealth.’

Cramer Calls Intel the “Number One Name” and “More Important Than NVIDIA.” The Stock Soars Today After a Massive Double Upgrade.

‘I Feel Like It’s 1999 Again.’ CNBC Analyst Issues Dire Warning on Oracle Stock

Why Delaying Social Security While Emptying Your 401(k) Can Slash Your Lifetime Taxes

Retiring With $1.8M in New Jersey Means an $11,400 Annual Tax Bill the Calculators Skip

Is Jeff Bezos’ New Startup An Even Bigger Idea than Amazon? He Tells CNBC it Will Drive ‘Civilizational Wealth.’

Cramer Calls Intel the “Number One Name” and “More Important Than NVIDIA.” The Stock Soars Today After a Massive Double Upgrade.

Health and Healthcare Articles

All Health and Healthcare Articles

Bad Diet Could Be to Blame for a Surprisingly High Share of Cancer Cases

Citigroup Sees Big Upside for 2 of the Largest Biotechs

How Tonix Pharma Is Kicking Cocaine

How Eli Lilly Is Making Insulin More Affordable

Why Ocular Therapeutix Fell Short in Its Glaucoma Study

Why BioCryst’s HAE Treatment Failed to Impress

We May Have Been Wrong About the Connection Between Coffee and Poop for Years

Thursday’s Top 4 ASCO Movers

Can Danaher Walk Away From the Buyout of GE’s Biopharma Unit?

Solid Breast Cancer Results From MacroGenics Ahead of ASCO

These Are the Most Used Drugs in the World — And Opioids Aren’t Even in the Top 5

Iovance Bio’s Big Break in Cervical Cancer Ahead of ASCO

Why Agilent Stock Plunged 12% After Earnings

Why There May Be a Big Issue With This Duchenne Muscular Dystrophy Study

The Best Biotech ETFs to Buy Ahead of ASCO

Is Jeff Bezos’ New Startup An Even Bigger Idea than Amazon? He Tells CNBC it Will Drive ‘Civilizational Wealth.’

Cramer Calls Intel the “Number One Name” and “More Important Than NVIDIA.” The Stock Soars Today After a Massive Double Upgrade.

‘I Feel Like It’s 1999 Again.’ CNBC Analyst Issues Dire Warning on Oracle Stock

Featured Reads

Why Delaying Social Security While Emptying Your 401(k) Can Slash Your Lifetime Taxes

Retiring With $1.8M in New Jersey Means an $11,400 Annual Tax Bill the Calculators Skip